Ignite Creation Date:
2025-12-25 @ 5:12 AM
Ignite Modification Date:
2025-12-26 @ 4:17 AM
Study NCT ID:
NCT01928927
Status:
COMPLETED
Last Update Posted:
2021-08-03
First Post:
2013-08-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)
Sponsor:
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-22
First Submit QC Date:
None
Study First Post Date:
2013-08-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-01
Results First Submit QC Date:
None
Results First Post Date:
2017-04-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-31
Last Update Post Date:
2021-08-03
Last Update Post Date Type:
ACTUAL